{"slug":"semax","verification":{"valid":true,"entries":45,"head":"e7a1af785900aca797d5abf08563201fb69389b2491aaab4301d08d4212746ea"},"energy":{"passes":45,"tokens_in":3157,"tokens_out":306,"tokens_total":3463,"cost_usd":0,"models":{"grok/grok-4.3":1,"grok-4.3":27,"repair":2,"system/audit-repair":11,"kimi/moonshot-v1-8k":1,"fill-slots":2,"owner":1},"head":"e7a1af785900aca797d5abf08563201fb69389b2491aaab4301d08d4212746ea"},"provenance":[{"ts":"2026-06-29T08:32:19.974Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):\nBPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).\nTB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.\nARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.\nSemax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.\nSelank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).\nPT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).\nDSIP — Delta Sleep Inducing Peptide; natural deep sleep without Ambien-class hangover.\nKPV — Gut-specific anti-inflammatory; calms gut lining without systemic immune suppression.\nGHK-Cu — Tissue remodeling; builds collagen scaffolding. Production drops 60-80% with age.\nThymosin Alpha-1 — Immune modulation; supports immune function without suppressing it.\n\nWrite a data-first, evidence-graded article: Semax: BDNF Upregulation\n\nGeneral evidence-graded intro for Semax: BDNF Upregulation. Data-first peptide definition article.\n\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate rat studies from human trials from user reports. No medical claims or treatment promises. Use repair-vs-suppression framing where relevant. register: source_ledger.","response":"{\n  \"slug\": \"semax-bdnf-upregulation\",\n  \"title\": \"Semax: BDNF Upregulation\",\n  \"body\": \"## Overview\\nSemax is described as a brain peptide that upregulates BDNF.\\n\\n## Preclinical Evidence (Rat Studies)\\nIn rat hippocampus, a single intranasal dose of Semax (50 μg/kg) produced a maximal 1.4-fold increase in BDNF protein levels, accompanied by increased trkB phosphorylation and mRNA expression (preclinical tier). [Dolotov et al., 2006]\\n\\nSimilar increases in BDNF protein were observed in rat basal forebrain after intranasal administration (preclinical tier).\\n\\n## Human Data\\nIn a study of 110 patients after ischemic stroke, Semax (two 10-day courses at 6000 μg/day) increased plasma BDNF levels regardless of rehabilitation timing (human tier). Higher BDNF levels correlated with improved motor performance and Barthel index scores.\\n\\nNo large-scale human trials on BDNF upregulation in healthy subjects or for cognitive enhancement in non-clinical populations were identified.\\n\\n## Mechanism Notes\\nSemax effects on BDNF are reported via modulation of expression in specific brain regions; no systemic immune suppression or masking of symptoms is described in the reviewed sources (mechanistic tier).\\n\\nProduction or baseline changes with age are not addressed in the primary sources cited.\",\n  \"register\": \"source_ledger\",\n  \"claims\": [\n    {\n      \"id\": \"c1\",\n      \"text\": \"In rat hippocampus, a single intranasal dose of Semax (50 μg/kg) produced a maximal 1.4-fold increase in BDNF protein levels, accompanied by increased trkB phosphorylation and mRNA expression.\",\n      \"section\": \"Preclinical Evidence (Rat Studies)\",\n      \"tier\": \"preclinical\",\n      \"source_ids\": [\"s1\"],\n      \"source_status\": \"sourced\",\n      \"why_material\": \"Core rat data establishing BDNF upregulation mechanism.\"\n    },\n    {\n      \"id\": \"c2\",\n      \"text\": \"In a study of 110 patients after ischemic stroke, Semax increased plasma BDNF levels.\",\n      \"section\": \"Human Data\",\n      \"tier\": \"human\",\n","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"8ba5f4ace44b22b6e1a409d70da89c778ab3153e29d11de39f0f4b4bb51d9b64"},{"ts":"2026-06-29T09:40:06.590Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8ba5f4ace44b22b6e1a409d70da89c778ab3153e29d11de39f0f4b4bb51d9b64","hash":"81b8dcfdf2bdd2c900e322a918ab90a92f6e21bac403d7b6ef755740b648c7f9"},{"ts":"2026-06-29T09:40:29.225Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"81b8dcfdf2bdd2c900e322a918ab90a92f6e21bac403d7b6ef755740b648c7f9","hash":"470f047844a3091249a4f8dd8205d436d4dd0795084bc683530c76752f414172"},{"ts":"2026-06-29T09:40:57.164Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"470f047844a3091249a4f8dd8205d436d4dd0795084bc683530c76752f414172","hash":"de746f28958949109261fc198888c0c04b425762c8ed516988d4b2b61490ebbe"},{"ts":"2026-06-29T09:41:19.154Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"de746f28958949109261fc198888c0c04b425762c8ed516988d4b2b61490ebbe","hash":"5ed7bd8590867b7dba34d11e904d529f72e62865154710cd53e1d31f53c6d469"},{"ts":"2026-06-29T09:42:07.195Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"5ed7bd8590867b7dba34d11e904d529f72e62865154710cd53e1d31f53c6d469","hash":"0571b644f45cf1db10447031fd9cc0821932f246ffc26014e040893320a55d1c"},{"ts":"2026-06-29T09:42:27.758Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0571b644f45cf1db10447031fd9cc0821932f246ffc26014e040893320a55d1c","hash":"523573cbb67ca36dffcdb09a45c255591bbf683df51790e353637523770550ea"},{"ts":"2026-06-29T09:42:44.833Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"7 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"523573cbb67ca36dffcdb09a45c255591bbf683df51790e353637523770550ea","hash":"e65fa0aec41651d556b492c5100ffe42b09aeaf0fa66fe115f293398adeb62a6"},{"ts":"2026-06-29T09:43:05.177Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"5 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e65fa0aec41651d556b492c5100ffe42b09aeaf0fa66fe115f293398adeb62a6","hash":"c367a552ef6b5a05b47649f13ba5d770b6bd2b31f3d9543169c35ebc8211f101"},{"ts":"2026-06-29T09:44:06.994Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c367a552ef6b5a05b47649f13ba5d770b6bd2b31f3d9543169c35ebc8211f101","hash":"0f9cae8c7be2b0e1aadbf715bc4248e75ae10856e3a83867374876ed9b58fe74"},{"ts":"2026-06-29T09:44:24.803Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0f9cae8c7be2b0e1aadbf715bc4248e75ae10856e3a83867374876ed9b58fe74","hash":"baa0e8f2a227e45e8bddc369c3ae8faaa5fa51f08c89e9dea93f746154bc8ff2"},{"ts":"2026-06-29T12:27:24.657Z","model":"repair","action":"repair","prompt":"","input":"semax","response":"{\"materialized\":53,\"before\":[\"3 claims missing posted_by\",\"53 orphan sources (no claim link)\",\"missing constitution slots: what_it_is, who_claims_what, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"baa0e8f2a227e45e8bddc369c3ae8faaa5fa51f08c89e9dea93f746154bc8ff2","hash":"f89fbdfc30d1a3ad945c3c2cf5480fec087e3c5dde87594652767bb790924eb0"},{"ts":"2026-06-29T12:45:12.178Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax","response":"{\"materialized\":0,\"before\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"],\"after\":[\"missing constitution slots: what_it_is, what_is_known, what_is_unknown, limitations, disclaimer\"]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f89fbdfc30d1a3ad945c3c2cf5480fec087e3c5dde87594652767bb790924eb0","hash":"71f50d7ce98ca28b2619f6f58eb53bedd1ee3101a11b0b2d3a6d1a98c0cd43af"},{"ts":"2026-06-29T12:45:12.757Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax c57","response":"Semax: BDNF Upregulation is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"71f50d7ce98ca28b2619f6f58eb53bedd1ee3101a11b0b2d3a6d1a98c0cd43af","hash":"cd1dde21f67718119a5ec010e2c9f19268886276a35bc0f11971f9d3728385ba"},{"ts":"2026-06-29T12:45:12.818Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax c58","response":"Per this ledger on Semax: BDNF Upregulation: 28 scientific and 25 anecdotal sources are catalogued; 13 preclinical claim(s) summarize animal/cell literature in-catalogue.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cd1dde21f67718119a5ec010e2c9f19268886276a35bc0f11971f9d3728385ba","hash":"d81b6f0d8065474833240d96e29ecb82b728ac2aa65507b22cb012e50d847866"},{"ts":"2026-06-29T12:45:12.896Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax c59","response":"Not established in this ledger: large randomized human trials for common marketed uses; long-term human safety beyond small pilots; condition-specific efficacy where only anecdotal or preclinical sources exist (explicit gaps remain in question graph).","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d81b6f0d8065474833240d96e29ecb82b728ac2aa65507b22cb012e50d847866","hash":"f6a6a556710b3c8dfd9ba44f938fdf85099c54db221a9f207321b4a48a493f00"},{"ts":"2026-06-29T12:45:12.963Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax c60","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f6a6a556710b3c8dfd9ba44f938fdf85099c54db221a9f207321b4a48a493f00","hash":"f56483c5e1036f8ec5a5251be2bfff34cc71644d77e7a977180f54c0a6997b53"},{"ts":"2026-06-29T12:45:13.035Z","model":"system/audit-repair","action":"claim","prompt":"","input":"semax c61","response":"Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f56483c5e1036f8ec5a5251be2bfff34cc71644d77e7a977180f54c0a6997b53","hash":"06a7cbd813d94f0e9c41ff161649ae1eb94f7d16837d281267a370e20e17f885"},{"ts":"2026-06-29T12:45:13.735Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"06a7cbd813d94f0e9c41ff161649ae1eb94f7d16837d281267a370e20e17f885","hash":"8bc76b5a4b4672fc99a6fb42413ae311ce52df4d1214f22fa994a1b56314bb41"},{"ts":"2026-06-29T12:45:58.117Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8bc76b5a4b4672fc99a6fb42413ae311ce52df4d1214f22fa994a1b56314bb41","hash":"1acba6eea0b38d974b567382e59c1cce14ca8ade0587b2c6e63ea7427ef7a415"},{"ts":"2026-06-29T12:45:59.379Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1acba6eea0b38d974b567382e59c1cce14ca8ade0587b2c6e63ea7427ef7a415","hash":"7ccc17cf0bd873f2567f76ccc6c9562083b58584d1050d39340e8c3474cbaa81"},{"ts":"2026-06-29T13:25:45.531Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"7ccc17cf0bd873f2567f76ccc6c9562083b58584d1050d39340e8c3474cbaa81","hash":"1b4ffb84c1b24928149dfae3f1f983903d4b52be96514d18d40913c74f4f8885"},{"ts":"2026-06-29T13:25:46.727Z","model":"system/audit-repair","action":"repair","prompt":"","input":"semax","response":"{\"materialized\":0,\"before\":[],\"after\":[]}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1b4ffb84c1b24928149dfae3f1f983903d4b52be96514d18d40913c74f4f8885","hash":"2b1f0b8d09f8821d1df5b705c0c7bb1800cf60d907bf0483490cf328062bab33"},{"ts":"2026-06-29T14:03:45.444Z","model":"kimi/moonshot-v1-8k","action":"collaborate","prompt":"","input":"semax","response":"I am adding claims that explicitly state gaps in knowledge and identify anecdotal claims, as these are missing from the ledger. I am not Grok because I am following the instructions to add specific types of claims that are not present in the ledger, rather than performing the role of Grok which involves different tasks.","tokens_in":3157,"tokens_out":306,"cost":0,"prev":"2b1f0b8d09f8821d1df5b705c0c7bb1800cf60d907bf0483490cf328062bab33","hash":"cd5c4619aa97e5f54173ae1ef9bcfd2169a1f33b104928c8768fe0d9c0b17a67"},{"ts":"2026-06-29T14:07:24.928Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cd5c4619aa97e5f54173ae1ef9bcfd2169a1f33b104928c8768fe0d9c0b17a67","hash":"159720761ad80eb3d8b338ad5985c043ed7becd0d8b4c33eb9de7934e3903594"},{"ts":"2026-06-29T14:07:45.729Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"1 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"159720761ad80eb3d8b338ad5985c043ed7becd0d8b4c33eb9de7934e3903594","hash":"3955ecac730722581c65e5f1edf0eecec3b670446554b36b468b675c7d832fcf"},{"ts":"2026-06-29T15:27:23.062Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"3955ecac730722581c65e5f1edf0eecec3b670446554b36b468b675c7d832fcf","hash":"ec125c4398f9f0c7e846e4985f10cfa19217f88b562488889b7234e7f631bf6c"},{"ts":"2026-06-29T15:27:58.873Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ec125c4398f9f0c7e846e4985f10cfa19217f88b562488889b7234e7f631bf6c","hash":"d5ae141c4c2311c80a7b07b4ac0201afca3b64ab5bf1cedd90c7de2912275b5e"},{"ts":"2026-06-29T15:28:25.529Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d5ae141c4c2311c80a7b07b4ac0201afca3b64ab5bf1cedd90c7de2912275b5e","hash":"e1b1c14a5c18ce7319d2dfe2226373f07d6d69c490a65e62accc3ea5acf77951"},{"ts":"2026-06-29T15:29:29.204Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e1b1c14a5c18ce7319d2dfe2226373f07d6d69c490a65e62accc3ea5acf77951","hash":"72b0dd98bd1ec58433190127da48d10476d472912f345ac3f35d5c33a6ea9e65"},{"ts":"2026-06-29T15:30:03.795Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"72b0dd98bd1ec58433190127da48d10476d472912f345ac3f35d5c33a6ea9e65","hash":"0efeb0162d8ed6958a148fda242f838efb1fb3c717e2bf09e4b23f2ffbccc5b8"},{"ts":"2026-06-29T15:30:35.650Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"4 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0efeb0162d8ed6958a148fda242f838efb1fb3c717e2bf09e4b23f2ffbccc5b8","hash":"cf32e20dfaa69a5c90fc4c09f0db6eaa99fd06b439f9ad7f4753b78aa4c933c8"},{"ts":"2026-06-29T15:31:37.590Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cf32e20dfaa69a5c90fc4c09f0db6eaa99fd06b439f9ad7f4753b78aa4c933c8","hash":"d028206b81825f349a58a7e9a2cc48c366f1e3438528bea89a18bf37defce57a"},{"ts":"2026-06-29T15:31:59.007Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"1 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d028206b81825f349a58a7e9a2cc48c366f1e3438528bea89a18bf37defce57a","hash":"14953535b270e9a603cf6b650f57ff2a2a80b707b05ada439c9f756af0b2e37e"},{"ts":"2026-06-29T15:32:24.429Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"14953535b270e9a603cf6b650f57ff2a2a80b707b05ada439c9f756af0b2e37e","hash":"6a3e52bd864ae8fa50a62d8dbf0f0b7656e8efc6f185e621d2a514a7ed10a6fb"},{"ts":"2026-06-29T15:33:19.845Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"1 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"6a3e52bd864ae8fa50a62d8dbf0f0b7656e8efc6f185e621d2a514a7ed10a6fb","hash":"2a0bf57be464b3757b62485c636357c5e93af92b18e20631925b245b0ff63471"},{"ts":"2026-06-29T15:33:41.185Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"1 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2a0bf57be464b3757b62485c636357c5e93af92b18e20631925b245b0ff63471","hash":"72717647379c28d0560f0fb564a26c8e23da3b6fff9e5e9b324f4d016e23a818"},{"ts":"2026-06-29T17:30:33.737Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"72717647379c28d0560f0fb564a26c8e23da3b6fff9e5e9b324f4d016e23a818","hash":"c0a82f18bcc306dba7ac842424d1e8ec823f0b991007f08776b4224d84971dbf"},{"ts":"2026-06-29T17:31:08.034Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c0a82f18bcc306dba7ac842424d1e8ec823f0b991007f08776b4224d84971dbf","hash":"d42af58833c8fac7b062f4b383d9d76f321a36b9ee32109e1d33559e0e738265"},{"ts":"2026-06-29T17:31:27.508Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"2 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"d42af58833c8fac7b062f4b383d9d76f321a36b9ee32109e1d33559e0e738265","hash":"b582bd40cb164c82a570e51b4e392825d0bfbb79f8839d3c7e99fe06f2ec9287"},{"ts":"2026-06-29T17:32:37.217Z","model":"grok-4.3","action":"sources","prompt":"","input":"semax","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"b582bd40cb164c82a570e51b4e392825d0bfbb79f8839d3c7e99fe06f2ec9287","hash":"c8ba92e5962d66c57a95c78977417bae1ae7975d0451652e7c4a94e3ba17b2c8"},{"ts":"2026-06-29T19:24:06.871Z","model":"repair","action":"repair","prompt":"","input":"semax","response":"{\"materialized\":0,\"before\":[],\"after\":[],\"focus_stats\":{\"roles_assigned\":0,\"excluded_sources\":0,\"commercial_sources\":0,\"cut_claims\":0,\"core\":0,\"cycle\":0,\"adjacent\":14}}","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c8ba92e5962d66c57a95c78977417bae1ae7975d0451652e7c4a94e3ba17b2c8","hash":"13563d57fa15fcd0c54f3dde2adf7dd12a010815e9d3bd2c7c18dedc1f4eb91a"},{"ts":"2026-06-29T20:38:04.884Z","model":"fill-slots","action":"claim","prompt":"","input":"semax c111","response":"Semax: BDNF Upregulation is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"13563d57fa15fcd0c54f3dde2adf7dd12a010815e9d3bd2c7c18dedc1f4eb91a","hash":"9d021bf424d35e5772e3079ca8b1645652e3e4db1d07a0bc04f81824e5ca253c"},{"ts":"2026-06-29T20:38:06.313Z","model":"fill-slots","action":"claim","prompt":"","input":"semax c112","response":"Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9d021bf424d35e5772e3079ca8b1645652e3e4db1d07a0bc04f81824e5ca253c","hash":"1ffa83b6b81b70f30f3e531f4ff497fbfbb58835b78e7a62aa635745d6e4708e"},{"ts":"2026-07-17T02:41:50.550Z","model":"owner","action":"voxel_divide","prompt":"","input":"semax","response":"11 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"1ffa83b6b81b70f30f3e531f4ff497fbfbb58835b78e7a62aa635745d6e4708e","hash":"e7a1af785900aca797d5abf08563201fb69389b2491aaab4301d08d4212746ea"}]}